ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 71 filers reported holding ALLOVIR INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,786,377 | -48.0% | 830,873 | -17.8% | 0.00% | 0.0% |
| Q2 2023 | $3,437,835 | -14.8% | 1,011,128 | -1.2% | 0.00% | 0.0% |
| Q1 2023 | $4,033,800 | -19.8% | 1,023,807 | +4.4% | 0.00% | -50.0% |
| Q4 2022 | $5,030,760 | -23.7% | 980,655 | +17.3% | 0.00% | 0.0% |
| Q3 2022 | $6,594,000 | +117.0% | 835,779 | +7.3% | 0.00% | +100.0% |
| Q2 2022 | $3,039,000 | -42.6% | 779,168 | -0.7% | 0.00% | -50.0% |
| Q1 2022 | $5,299,000 | -46.4% | 785,020 | +2.8% | 0.00% | -33.3% |
| Q4 2021 | $9,877,000 | -48.7% | 763,329 | -0.7% | 0.00% | -50.0% |
| Q3 2021 | $19,270,000 | +59.6% | 768,948 | +25.7% | 0.01% | +50.0% |
| Q2 2021 | $12,072,000 | -15.9% | 611,552 | -0.3% | 0.00% | 0.0% |
| Q1 2021 | $14,353,000 | -40.5% | 613,355 | -2.3% | 0.00% | -50.0% |
| Q4 2020 | $24,131,000 | +42.4% | 627,755 | +1.9% | 0.01% | +33.3% |
| Q3 2020 | $16,942,000 | – | 616,089 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |